• 2015
  Muslin C, Joffret ML, Pelletier I, Blondel B, Delpeyroux F, Evolution and Emergence of Enteroviruses through Intra- and Inter-species Recombination: Plasticity and Phenotypic Impact of Modular Genetic Exchanges in the 5′ Untranslated Region, PLoS Pathog. 2015 Nov;11(11):e1005266.
• 2013
  Téoulé F, Brisac C, Pelletier I, Vidalain PO, Jégouic S, Mirabelli C, Bessaud M, Combelas N, Autret A, Tangy F, Delpeyroux F, Blondel B, The Golgi protein ACBD3, an interactor for poliovirus protein 3A, modulates poliovirus replication, J. Virol. 2013 Oct;87(20):11031-46.
• 2011
  Pelletier I, Rousset D, Enouf V, , Colbere-Garapin F, van der Werf S, Naffakh N, Highly heterogeneous temperature sensitivity of 2009 pandemic influenza A(H1N1) viral isolates, northern France, Euro Surveill. 2011 Oct;16(43).
• 2010
  Brisac C, Téoulé F, Autret A, Pelletier I, Colbère-Garapin F, Brenner C, Lemaire C, Blondel B, Calcium flux between the endoplasmic reticulum and mitochondrion contributes to poliovirus-induced apoptosis, J. Virol. 2010 Dec;84(23):12226-35.
• 2010
  Pelletier I, Saulnier A, Brisac C, Jegouic S, Vabret N, Tangy F, Blondel B, Colbère-Garapin F, Enhanced gene silencing in cells cured of persistent virus infection by RNA interference, J. Virol. 2010 Jul;84(13):6880-5.
• 2009
  Jegouic S, Joffret ML, Blanchard C, Riquet FB, Perret C, Pelletier I, Colbere-Garapin F, Rakoto-Andrianarivelo M, Delpeyroux F, Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses, PLoS Pathog. 2009 May;5(5):e1000412.
• 2009
  Blondel B, Autret A, Brisac C, Martin-Latil S, Mousson L, Pelletier I, Estaquier J, Colbere-Garapin F, Apoptotic signaling cascades operating in poliovirus-infected cells, Front Biosci (Landmark Ed) 2009;14:2181-92.
• 2008
  Blondel B, Autret A, Brisac C, Pelletier I, Martin-Latil S, Jegouic S, Bessaud M, Joffret ML, Balanant J, Colbère-Garapin F, Delpeyroux F, [Genetic evolution of poliovirus: success and difficulties in the eradication of paralytic poliomyelitis], Med Trop (Mars) 2008 Apr;68(2):189-202.
• 2007
  Colbère-Garapin F, Martin-Latil S, Blondel B, Mousson L, Pelletier I, Autret A, François A, Niborski V, Grompone G, Catonnet G, van de Moer A, Prevention and treatment of enteric viral infections: possible benefits of probiotic bacteria, Microbes Infect. 2007 Nov-Dec;9(14-15):1623-31.
• 2005
  Saulnier A, Pelletier I, Labadie K, Colbère-Garapin F, Complete cure of persistent virus infections by antiviral siRNAs, Mol. Ther. 2006 Jan;13(1):142-50.
• 2005
  Colbère-Garapin F, Blondel B, Saulnier A, Pelletier I, Labadie K, Silencing viruses by RNA interference, Microbes Infect. 2005 Apr;7(4):767-75.
• 2004
  Labadie K, Pelletier I, Saulnier A, Martin J, Colbère-Garapin F, Poliovirus mutants excreted by a chronically infected hypogammaglobulinemic patient establish persistent infections in human intestinal cells, Virology 2004 Jan;318(1):66-78.
• 2003
  Pelletier I, Ouzilou L, Arita M, Nomoto A, Colbère-Garapin F, Characterization of the poliovirus 147S particle: new insights into poliovirus uncoating, Virology 2003 Jan;305(1):55-65.
• 2002
  Ouzilou L, Caliot E, Pelletier I, Prévost MC, Pringault E, Colbère-Garapin F, Poliovirus transcytosis through M-like cells, J. Gen. Virol. 2002 Sep;83(Pt 9):2177-82.
• 2002
  Girard S, Gosselin AS, Pelletier I, Colbère-Garapin F, Couderc T, Blondel B, Restriction of poliovirus RNA replication in persistently infected nerve cells, J. Gen. Virol. 2002 May;83(Pt 5):1087-93.
• 2001
  Colbère-Garapin F, Jacques S, Drillet AS, Pavio N, Couderc T, Blondel B, Pelletier I, Poliovirus persistence in human cells in vitro, Dev Biol (Basel) 2001;105:99-104.
• 2001
  Couderc T, Girard S, Pelletier I, Gosselin AS, Destombes J, Thiesson D, Colbère-Garapin F, Blondel B, Inhibition of poliovirus RNA synthesis as a molecular mechanism contributing to viral persistence in the mouse central nervous system, Dev Biol (Basel) 2001;105:225-30.
• 1998
  Pelletier I, Duncan G, Pavio N, Colbère-Garapin F, Molecular mechanisms of poliovirus persistence: key role of capsid determinants during the establishment phase, Cell. Mol. Life Sci. 1998 Dec;54(12):1385-402.
• 1998
  Colbére-Garapin F, Duncan G, Pavio N, Pelletier I, Petit I, An approach to understanding the mechanisms of poliovirus persistence in infected cells of neural or non-neural origin, Clin Diagn Virol 1998 Apr;9(2-3):107-13.
• 1998
  Duncan G, Pelletier I, Colbère-Garapin F, Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus-receptor interactions, Virology 1998 Feb;241(1):14-29.
• 1998
  Pelletier I, Duncan G, Colbère-Garapin F, One amino acid change on the capsid surface of poliovirus sabin 1 allows the establishment of persistent infections in HEp-2c cell cultures, Virology 1998 Feb;241(1):1-13.